Show simple item record

dc.contributor.authorO'Dea, Angela
dc.contributor.authorInfanti, Jennifer J.
dc.contributor.authorGillespie, Paddy
dc.contributor.authorTummon, Olga
dc.contributor.authorFanous, Samuel
dc.contributor.authorGlynn, Liam G.
dc.contributor.authorMcGuire, Brian
dc.contributor.authorNewell, John
dc.date.accessioned2014-05-22T09:25:34Z
dc.date.available2014-05-22T09:25:34Z
dc.date.issued2014-01-17
dc.identifier.citationO'Dea, A., Infanti, J., Gillespie, P., Tummon, O., Fanous, S., Glynn, L., et al. Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trial. Trials, 15(1), 27.en_US
dc.identifier.issn1745-6215
dc.identifier.urihttp://hdl.handle.net/10379/4377
dc.descriptionJournal articleen_US
dc.description.abstractThe risks associated with gestational diabetes mellitus (GDM) are well recognized, and there is increasing evidence to support treatment of the condition. However, clear guidance on the ideal approach to screening for GDM is lacking. Professional groups continue to debate whether selective screening (based on risk factors) or universal screening is the most appropriate approach. Additionally, there is ongoing debate about what levels of glucose abnormalities during pregnancy respond best to treatment and which maternal and neonatal outcomes benefit most from treatment. Furthermore, the implications of possible screening options on health care costs are not well established. In response to this uncertainty there have been repeated calls for well-designed, randomised trials to determine the efficacy of screening, diagnosis, and management plans for GDM. We describe a randomised controlled trial to investigate screening uptake rates and the clinical and cost effectiveness of screening in primary versus secondary care settings.en_US
dc.description.sponsorshipHRB Irelanden_US
dc.formatapplication/pdfen_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.relation.ispartofTrialsen
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectGestational diabetes mellitusen_US
dc.subjectScreeningen_US
dc.subjectPrimary careen_US
dc.subjectSecondary careen_US
dc.subjectRandomised controlled trialen_US
dc.titleScreening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trialen_US
dc.typeArticleen_US
dc.date.updated2014-05-21T13:02:37Z
dc.local.publishedsourcehttp://dx.doi.10.1186/1745-6215-15-27en_US
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funder|~|
dc.internal.rssid5701681
dc.local.contactAngela O'Dea, School Of Medicine, 1 Distillery Road, Nui Galway. 3608 Email: angela.odea@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionPUBLISHED
nui.item.downloads389


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland